Anti-inflammatory, analgesic and antipyretic activities of 6-chloro-5-cyclohexylindan-1-carboxylic acid (TAI-284).
D000700:Analgesics; D000818:Animals; D000893:Anti-Inflammatory Agents; D001168:Arthritis / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000494:pharmacology; D002199:Capillary Permeability / Q000187:drug effects; D004396:Coloring Agents; D003510:Cyclohexanes / Q000627:therapeutic use; D003864:Depression, Chemical; D003907:Dexamethasone / Q000494:pharmacology; D004285:Dogs; D004487:Edema / Q000188:drug therapy; D006099:Granuloma / Q000188:drug therapy; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007192:Indenes / Q000627:therapeutic use*; D007213:Indomethacin / Q000494:pharmacology; D008112:Liver Glycogen / Q000032:analysis; D008528:Mefenamic Acid / Q000494:pharmacology; D051379:Mice; D010653:Phenylbutazone / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012702:Serotonin Antagonists
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D004396:Coloring Agents; D003510:Cyclohexanes; D006634:Histamine H1 Antagonists; D007192:Indenes; D008112:Liver Glycogen; D012702:Serotonin Antagonists; D008528:Mefenamic Acid; D003907:Dexamethasone; D010653:Phenylbutazone; D007213:Indomethacin